The choice of the noninferiority margin in clinical trials was driven by baseline risk, type of primary outcome, and benefits of new treatment
| Image |  |
|---|---|
| Description | scientific article published on 28 January 2015 |
| Author/s |
author: Angèle Gayet-Ageron Thomas Agoritsas |
| Publication date | January 28, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |